• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢曲松治疗实验性大肠杆菌脑膜炎期间体外时间-杀菌曲线与脑脊液中细菌杀灭动力学的相关性

Correlation of in vitro time-kill curves and kinetics of bacterial killing in cerebrospinal fluid during ceftriaxone therapy of experimental Escherichia coli meningitis.

作者信息

Decazes J M, Ernst J D, Sande M A

出版信息

Antimicrob Agents Chemother. 1983 Oct;24(4):463-7. doi: 10.1128/AAC.24.4.463.

DOI:10.1128/AAC.24.4.463
PMID:6316841
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC185356/
Abstract

Ceftriaxone was highly active in eliminating Escherichia coli from the cerebrospinal fluid of rabbits infected with experimental meningitis. However, concentrations equal to or greater than 10 times the minimal bactericidal concentration had to be achieved to ensure optimal efficacy (rate of kill, 1.5 log10 CFU/ml per h). In contrast to other beta-lactams studied in this model, ceftriaxone concentrations in cerebrospinal fluid progressively increased, whereas serum steady state was obtained by constant infusion. The percent penetration was 2.1% after 1 h of therapy, in contrast to 8.9% after 7 h (P less than 0.001). In vitro time-kill curves done in cerebrospinal fluid or broth more closely predicted the drug concentrations required for a maximum cidal effect in vivo than that predicted by determinations of minimal inhibitory or bactericidal concentrations.

摘要

头孢曲松在清除感染实验性脑膜炎的兔脑脊液中的大肠杆菌方面具有高度活性。然而,必须达到等于或大于最低杀菌浓度10倍的浓度才能确保最佳疗效(杀菌速率,每小时1.5 log10 CFU/ml)。与该模型中研究的其他β-内酰胺类药物不同,脑脊液中的头孢曲松浓度逐渐升高,而通过持续输注可获得血清稳态。治疗1小时后的穿透率为2.1%,而7小时后为8.9%(P小于0.001)。在脑脊液或肉汤中进行的体外时间-杀菌曲线比通过测定最低抑菌或杀菌浓度所预测的更能准确预测体内最大杀菌效果所需的药物浓度。

相似文献

1
Correlation of in vitro time-kill curves and kinetics of bacterial killing in cerebrospinal fluid during ceftriaxone therapy of experimental Escherichia coli meningitis.头孢曲松治疗实验性大肠杆菌脑膜炎期间体外时间-杀菌曲线与脑脊液中细菌杀灭动力学的相关性
Antimicrob Agents Chemother. 1983 Oct;24(4):463-7. doi: 10.1128/AAC.24.4.463.
2
Evaluation of pefloxacin in experimental Escherichia coli meningitis.培氟沙星在实验性大肠杆菌脑膜炎中的评估。
Antimicrob Agents Chemother. 1986 Mar;29(3):409-11. doi: 10.1128/AAC.29.3.409.
3
Comparative efficacy of cefotiam, cefmenoxime, and ceftriaxone in experimental endocarditis and correlation with pharmacokinetics and in vitro efficacy.头孢替安、头孢甲肟和头孢曲松在实验性心内膜炎中的疗效比较及其与药代动力学和体外疗效的相关性。
Antimicrob Agents Chemother. 1987 Apr;31(4):518-22. doi: 10.1128/AAC.31.4.518.
4
Evaluation of piperacillin-tazobactam in experimental meningitis caused by a beta-lactamase-producing strain of K1-positive Escherichia coli.哌拉西林-他唑巴坦对产β-内酰胺酶的K1阳性大肠杆菌所致实验性脑膜炎的疗效评估
Antimicrob Agents Chemother. 1990 May;34(5):697-701. doi: 10.1128/AAC.34.5.697.
5
Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis.头孢曲松治疗小儿细菌性脑膜炎的药代动力学及脑脊液杀菌活性
Antimicrob Agents Chemother. 1982 Oct;22(4):622-7. doi: 10.1128/AAC.22.4.622.
6
Rationale for clinical trials evaluating ceftriaxone in the therapy of bacterial meningitis.评估头孢曲松治疗细菌性脑膜炎的临床试验原理。
Am J Med. 1984 Oct 19;77(4C):42-9.
7
Efficacy of cefmenoxime in experimental Escherichia coli bacteremia and meningitis.头孢甲肟在实验性大肠杆菌菌血症和脑膜炎中的疗效。
Antimicrob Agents Chemother. 1985 Sep;28(3):389-92. doi: 10.1128/AAC.28.3.389.
8
Pharmacokinetics of ceftriaxone in pediatric patients with meningitis.头孢曲松在患脑膜炎儿科患者中的药代动力学。
Antimicrob Agents Chemother. 1983 Feb;23(2):191-4. doi: 10.1128/AAC.23.2.191.
9
Efficacy of cefotaxime and latamoxef for Escherichia coli bacteremia and meningitis in newborn rats.头孢噻肟和拉氧头孢对新生大鼠大肠杆菌菌血症和脑膜炎的疗效。
Chemotherapy. 1984;30(4):262-9. doi: 10.1159/000238278.
10
Diffusion of ceftriaxone into the cerebrospinal fluid of adults.
J Antimicrob Chemother. 1984 Oct;14(4):427-30. doi: 10.1093/jac/14.4.427.

引用本文的文献

1
Cerebrospinal fluid penetration of very high-dose meropenem: a case report.超高剂量美罗培南的脑脊液穿透:一例报告。
Ann Clin Microbiol Antimicrob. 2018 Dec 29;17(1):47. doi: 10.1186/s12941-018-0299-0.
2
Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.抗菌药物在脑脊液中的临床药代动力学。
Clin Pharmacokinet. 2013 Jul;52(7):511-42. doi: 10.1007/s40262-013-0062-9.
3
Killing activities of trovafloxacin alone and in combination with beta-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically achievable in cerebrospinal fluid.曲伐沙星单独及与β-内酰胺类药物、利福平或万古霉素联合使用时,针对在脑脊液中可达到的临床浓度下对超广谱头孢菌素具有不同敏感性的肺炎链球菌分离株的杀菌活性。
Antimicrob Agents Chemother. 1999 Oct;43(10):2372-5. doi: 10.1128/AAC.43.10.2372.
4
Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis.头孢曲松治疗实验性耐头孢菌素肺炎球菌性脑膜炎的药效学及杀菌活性
Antimicrob Agents Chemother. 1997 Nov;41(11):2414-7. doi: 10.1128/AAC.41.11.2414.
5
Different ratios of the piperacillin-tazobactam combination for treatment of experimental meningitis due to Klebsiella pneumoniae producing the TEM-3 extended-spectrum beta-lactamase.不同比例的哌拉西林-他唑巴坦组合用于治疗由产TEM-3超广谱β-内酰胺酶的肺炎克雷伯菌引起的实验性脑膜炎。
Antimicrob Agents Chemother. 1994 Feb;38(2):195-9. doi: 10.1128/AAC.38.2.195.
6
In vitro killing activities of antibiotics at clinically achievable concentrations in cerebrospinal fluid against penicillin-resistant Streptococcus pneumoniae isolated from children with meningitis.脑脊液中临床可达到浓度的抗生素对从脑膜炎患儿分离出的耐青霉素肺炎链球菌的体外杀伤活性。
Antimicrob Agents Chemother. 1994 Nov;38(11):2655-9. doi: 10.1128/AAC.38.11.2655.
7
Comparison of ceftriaxone and ampicillin plus chloramphenicol for the therapy of acute bacterial meningitis.头孢曲松与氨苄青霉素加氯霉素治疗急性细菌性脑膜炎的比较。
Antimicrob Agents Chemother. 1985 Sep;28(3):361-8. doi: 10.1128/AAC.28.3.361.
8
Cefotaxime diffusion into cerebrospinal fluid of children with meningitis.头孢噻肟在患脑膜炎儿童脑脊液中的扩散。
Antimicrob Agents Chemother. 1985 Jul;28(1):138-40. doi: 10.1128/AAC.28.1.138.
9
Bactericidal activity of cefotaxime and fosfomycin in cerebrospinal fluid during the treatment of rabbit meningitis experimentally induced by methicillin-resistant Staphylococcus aureus.头孢噻肟和磷霉素在由耐甲氧西林金黄色葡萄球菌实验性诱导的兔脑膜炎治疗期间脑脊液中的杀菌活性。
Infection. 1985;13 Suppl 1:S76-80. doi: 10.1007/BF01644224.
10
The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy.
Clin Pharmacokinet. 1986 Nov-Dec;11(6):470-82. doi: 10.2165/00003088-198611060-00004.

本文引用的文献

1
Pharmacokinetics of Ro 13-9904, a broad-spectrum cephalosporin.广谱头孢菌素Ro 13-9904的药代动力学
Antimicrob Agents Chemother. 1980 Aug;18(2):240-2. doi: 10.1128/AAC.18.2.240.
2
Treatment of purulent meningitis with a new cephalosporin-Rocephin (Ro 13-9904). Clinical, bacteriological and pharmacological observations in 24 cases.用新型头孢菌素——罗氏芬(Ro 13 - 9904)治疗化脓性脑膜炎。24例临床、细菌学及药理学观察
Chemotherapy. 1981;27 Suppl 1:57-61. doi: 10.1159/000238030.
3
Effects of concentration-dependent plasma protein binding on ceftriaxone kinetics.浓度依赖性血浆蛋白结合对头孢曲松动力学的影响。
Clin Pharmacol Ther. 1981 May;29(5):650-7. doi: 10.1038/clpt.1981.90.
4
Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits.兔实验性肺炎球菌性脑膜炎的杀菌与抑菌抗生素治疗
J Clin Invest. 1983 Mar;71(3):411-9. doi: 10.1172/jci110785.
5
The new beta-lactamase-stable cephalosporins.新型β-内酰胺酶稳定的头孢菌素。
Ann Intern Med. 1982 Sep;97(3):408-19. doi: 10.7326/0003-4819-97-3-408.
6
In vitro activity of Ro 13-9904, a new beta-lactamase-stable cephalosporin.新型β-内酰胺酶稳定型头孢菌素Ro 13-9904的体外活性
Antimicrob Agents Chemother. 1981 Feb;19(2):222-5. doi: 10.1128/AAC.19.2.222.
7
Efficacy of ceftriaxone in serious bacterial infections.头孢曲松在严重细菌感染中的疗效。
Antimicrob Agents Chemother. 1982 Mar;21(3):402-6. doi: 10.1128/AAC.21.3.402.
8
Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.头孢哌酮、头孢曲松和拉氧头孢在实验性肺炎链球菌和流感嗜血杆菌脑膜炎中的药代动力学及细菌学疗效
Antimicrob Agents Chemother. 1982 Feb;21(2):262-7. doi: 10.1128/AAC.21.2.262.
9
Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis.羟羧氧酰胺菌素、头孢噻肟、头孢哌酮和头孢曲松在实验性细菌性脑膜炎中的药代动力学及细菌学疗效
J Infect Dis. 1981 Feb;143(2):156-63. doi: 10.1093/infdis/143.2.156.
10
[The antibiotic therapy laboratory in purulent meningitis].
Sem Hop. 1967 Jan 20;43(4):239-42.